Literature DB >> 22171492

[A case of lung injury induced by long-term administration of mesalazine].

Yuriko Shindoh1, Ryo Horaguchi, Katsutoshi Hayashi, Yuji Suda, Hideya Iijima, Chiyohiko Shindoh.   

Abstract

A 52-year-old man was given a diagnosis of ulcerative colitis and treated with mesalazine for 7.5 years. However, the unusually long administration of mesalazine induced lung injury and the patient complained of a dry cough and dyspnea on limited exertion. Infiltrative shadows were observed in bilateral lung fields on a chest radiograph and computed tomographic images. The histological findings obtained by transbronchial biopsy and bronchoalveolar lavage showed organizing pneumonia. His drug-induced lymphocyte stimulation test (DLST) for mesalazine was positive. Improvements in his clinical symptoms and radiographic abnormalities occurred spontaneously after the discontinuation of mesalazine. This case indicates that the long-term administration of mesalazine may lead to an adverse pulmonary reaction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171492

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review.

Authors:  Yunjian Zhang; Ling Luo; Xiaofang Wang; Xiaoyang Liu; Xiaoyan Wang; Yi Ding
Journal:  Ther Clin Risk Manag       Date:  2016-06-14       Impact factor: 2.423

2.  Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.

Authors:  Po-Han Huang; Chia-Jung Kuo; Chang-Wei Lin; Yu-Ming Cheng; Han-Chung Hu; Chun-Yen Lin; Ming-Yao Su; Cheng-Tang Chiu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

3.  Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation.

Authors:  Hajime Oi; Atsushi Suzuki; Yasuhiko Yamano; Toshiki Yokoyama; Toshiaki Matsuda; Kensuke Kataoka; Yasuhiko Suzuki; Tomoki Kimura; Yasuhiro Kondoh
Journal:  Respir Med Case Rep       Date:  2020-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.